Molecular structure of 2,5-Dihydro-4-methyl-2,5-dioxo-3-furanpropanoic acid, CAS Number: 487-66-1
2,5-Dihydro-4-methyl-2,5-dioxo-3-furanpropanoic acid (CAS 487-66-1)
Alternate Names:
2-(2-Carboxyethyl)-3-methylmaleic
CAS Number:
487-66-1
Molecular Weight:
184.15
Molecular Formula:
C8H8O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
2,5-Dihydro-4-methyl-2,5-dioxo-3-furanpropanoic Acid exhibits diverse biochemical effects. It has been observed to possess inhibitory properties against enzymes responsible for generating inflammatory mediators, including cyclooxygenase-2. Furthermore, it demonstrates antioxidant activity by reducing the formation of reactive oxygen species.
2,5-Dihydro-4-methyl-2,5-dioxo-3-furanpropanoic acid (CAS 487-66-1) References
- Solid-phase synthesis of protein-polymers on reversible immobilization supports. | Murata, H., et al. 2018. Nat Commun. 9: 845. PMID: 29487296
- Codelivery of Anti-PD-1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual-Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy. | Su, Z., et al. 2020. Small. 16: e1906832. PMID: 31990457
- Ultrasound-Augmented Mitochondrial Calcium Ion Overload by Calcium Nanomodulator to Induce Immunogenic Cell Death. | Zheng, P., et al. 2021. Nano Lett. 21: 2088-2093. PMID: 33596078
- Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy. | Su, Z., et al. 2021. ACS Appl Mater Interfaces. 13: 12845-12856. PMID: 33709684
- A tumor extracellular pH-sensitive PD-L1 binding peptide nanoparticle for chemo-immunotherapy of cancer. | Zhu, W., et al. 2021. J Mater Chem B. 9: 4201-4210. PMID: 33997867
- Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy. | Wang, K., et al. 2022. ACS Nano. 16: 721-735. PMID: 34978422
- Spatial specific delivery of combinational chemotherapeutics to combat intratumoral heterogeneity. | Wang, K., et al. 2022. J Control Release. 348: 1004-1015. PMID: 35779654
- Co-delivery of proanthocyanidin and mitoxantrone induces synergistic immunogenic cell death to potentiate cancer immunotherapy. | Qian, Y., et al. 2022. Biomater Sci. 10: 4549-4560. PMID: 35790120
- Inflammation-Regulated Nanodrug Sensitizes Hepatocellular Carcinoma to Checkpoint Blockade Therapy by Reprogramming the Tumor Microenvironment. | Wang, T., et al. 2022. ACS Appl Mater Interfaces.. PMID: 36314479
- Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy. | Wang, T., et al. 2023. Colloids Surf B Biointerfaces. 225: 113277. PMID: 36996630
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
2,5-Dihydro-4-methyl-2,5-dioxo-3-furanpropanoic acid, 1 g | sc-489785 | 1 g | $235.00 |